KRYSTAL BIOTECH INC's ticker is KRYS and the CUSIP is 501147102. A total of 137 filers reported holding KRYSTAL BIOTECH INC in Q1 2022. The put-call ratio across all filers is 0.67 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $2,369,416 | +76.2% | 20,426 | +21.6% | 0.00% | 0.0% |
| Q2 2023 | $1,344,448 | 0.0% | 16,793 | 0.0% | 0.00% | 0.0% |
| Q1 2023 | $1,344,448 | +9.7% | 16,793 | +8.5% | 0.00% | 0.0% |
| Q4 2022 | $1,225,612 | -99.9% | 15,471 | -4.3% | 0.00% | 0.0% |
| Q3 2022 | $1,127,188,000 | +12.9% | 16,172 | +6.3% | 0.00% | 0.0% |
| Q2 2022 | $998,491,000 | -1.3% | 15,207 | 0.0% | 0.00% | – |
| Q1 2022 | $1,011,874,000 | +41.9% | 15,207 | +49.2% | 0.00% | – |
| Q4 2021 | $713,001,000 | +56.9% | 10,193 | +17.1% | 0.00% | – |
| Q3 2021 | $454,488,000 | -23.2% | 8,705 | 0.0% | 0.00% | – |
| Q2 2021 | $591,940,000 | -18.0% | 8,705 | -7.1% | 0.00% | – |
| Q1 2021 | $721,634,000 | +12.8% | 9,367 | -12.2% | 0.00% | – |
| Q4 2020 | $640,020,000 | +39.4% | 10,667 | 0.0% | 0.00% | – |
| Q3 2020 | $459,214,000 | +105.3% | 10,667 | +97.5% | 0.00% | – |
| Q2 2020 | $223,668,000 | -11.8% | 5,400 | -8.0% | 0.00% | – |
| Q1 2020 | $253,689,000 | +11.7% | 5,867 | +43.1% | 0.00% | – |
| Q4 2019 | $227,058,000 | – | 4,100 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| FRAZIER MANAGEMENT LLC | 895,000 | $38,700,000 | 4.39% |
| S Squared Technology, LLC | 60,215 | $2,604,000 | 2.53% |
| Consonance Capital Management LP | 654,586 | $28,304,000 | 2.11% |
| Redmile Group, LLC | 1,051,800 | $45,480,000 | 1.28% |
| EAM Investors, LLC | 69,430 | $3,002,000 | 0.93% |
| EAM Global Investors LLC | 30,065 | $1,300,000 | 0.76% |
| Nicholas Investment Partners, LP | 81,916 | $3,542,000 | 0.69% |
| Baker Brothers Advisors | 946,471 | $40,925,000 | 0.25% |
| KNOTT DAVID M | 7,079 | $306,000 | 0.19% |
| Atom Investors LP | 48,201 | $2,084,000 | 0.18% |